ATAI Life Stock Analysis

ATAI
 Stock
  

USD 3.34  0.19  5.38%   

The current ATAI Life Sciences price drop could raise concerns from stockholders as the firm is trading at a share price of 3.34 on 873,010 in volume. The company directors and management were unable to exploit market volatilities in November. However, diversifying your overall positions with ATAI Life can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.85. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the ATAI Life Sciences partners.
Please continue to Trending Equities.
  
The ATAI Life stock analysis report makes it easy to digest most publicly released information about ATAI Life and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ATAI Life Stock analysis module also helps to analyze the ATAI Life price relationship with some important fundamental indicators such as market cap and management efficiency.

ATAI Life Stock Analysis Notes

About 35.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.77. Some equities with similar Price to Book (P/B) outperform the market in the long run. ATAI Life Sciences recorded a loss per share of 1.4. The entity last dividend was issued on the 27th of August 2018. Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on ATAI Life Sciences please contact Xiaofeng Ma at 49 89 2153 9035 or go to https://www.atai.life.

ATAI Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ATAI Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ATAI Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ATAI Life Sciences generated a negative expected return over the last 90 days
ATAI Life Sciences has high historical volatility and very poor performance
The company reported the previous year's revenue of 20.38 M. Net Loss for the year was (167.81 M) with profit before overhead, payroll, taxes, and interest of 20.38 M.
ATAI Life Sciences currently holds about 304.06 M in cash with (63.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83.

ATAI Life Sciences Upcoming and Recent Events

Earnings reports are used by ATAI Life to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ATAI Life previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of February 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End21st of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

ATAI Life Largest EPS Surprises

Earnings surprises can significantly impact ATAI Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-08-16
2021-06-30-0.18-0.37-0.19105 
2022-03-30
2021-12-31-0.23-0.62-0.39169 
2021-05-27
2021-03-310.01-0.57-0.585800 
View All Earnings Estimates

ATAI Life SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. ATAI Life prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that ATAI Life investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial ATAI Life Sciences specific information freely available to individual and institutional investors to make a timely investment decision.
15th of August 2022
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
View
1st of August 2022
Unregistered Sales of Equity Securities
View
17th of June 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
27th of May 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
View
16th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
30th of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
1st of March 2022
Unclassified Corporate Event
View
10th of February 2022
Unclassified Corporate Event
View

ATAI Life Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as ATAI Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATAI Life Sciences backward and forwards among themselves. ATAI Life's institutional investor refers to the entity that pools money to purchase ATAI Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares22 K71 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares22 K80 K
Xtx Topco LtdCommon Shares17.8 K136 K
Woodline Partners LpCommon Shares925.2 K3.1 M
Woodline Partners LpCommon Shares750 K2.7 M
Woodline Partners LpCommon Shares763.9 K3.9 M
Woodline Partners LpCommon Shares838 K6.4 M
Note, although ATAI Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ATAI Life Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 585.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ATAI Life's market, we take the total number of its shares issued and multiply it by ATAI Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (0.22) % which means that it has lost $0.22 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.5378) %, meaning that it created substantial loss on money invested by shareholders. ATAI Life management efficiency ratios could be used to measure how well atai life sciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of December, ATAI Life owns the coefficient of variation of (1,563), and Market Risk Adjusted Performance of (0.23). ATAI Life Sciences technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for ATAI Life, which can be compared to its peers in the sector. Please confirm ATAI Life Sciences jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if ATAI Life Sciences is priced correctly, providing market reflects its prevailing price of 3.34 per share. Given that ATAI Life Sciences has jensen alpha of (0.40), we suggest you to validate ATAI Life's latest market performance to make sure the company can sustain itself in the future.

ATAI Life Sciences Price Movement Analysis

The output start index for this execution was six with a total number of output elements of fifty-five. The Mid-point Price over period is an average of ATAI Life Sciences highest and lowest prices attained during the given period.
.

ATAI Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ATAI Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ATAI Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ATAI Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bardin Stephen over three months ago via Macroaxis 
Atai Life exotic insider transaction detected
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 68688 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 21900 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 19803 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 8961 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 65315 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 4967 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 55197 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 53926 shares of Atai Life
Apeiron Investment Group Ltd over six months ago via Macroaxis 
Purchase by Apeiron Investment Group Ltd of 1000000 shares of Atai Life
Rao Srinivas over six months ago via Macroaxis 
Acquisition by Rao Srinivas of 519240 shares of Atai Life subject to Rule 16b-3
Auerbach Michael over six months ago via Macroaxis 
Atai Life exotic insider transaction detected

ATAI Life Predictive Daily Indicators

ATAI Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ATAI Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ATAI Life Forecast Models

ATAI Life time-series forecasting models is one of many ATAI Life's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ATAI Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About ATAI Life Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ATAI Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ATAI Life shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as ATAI Life. By using and applying ATAI Life Stock analysis, traders can create a robust methodology for identifying ATAI Life entry and exit points for their positions.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.

Current ATAI Life Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ATAI Life analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ATAI Life analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
31.78Buy9Odds
ATAI Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ATAI Life analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ATAI Life stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ATAI Life Sciences, talking to its executives and customers, or listening to ATAI Life conference calls.
ATAI Life Analyst Advice Details

ATAI Life Stock Analysis Indicators

ATAI Life Sciences stock analysis indicators help investors evaluate how ATAI Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ATAI Life shares will generate the highest return on investment. By understating and applying ATAI Life stock analysis, traders can identify ATAI Life position entry and exit signals to maximize returns.
Begin Period Cash Flow97246000.00
Common Stock Shares Outstanding152569776.00
Total Stockholder Equity376908000.00
Total Cashflows From Investing Activities-81276000.00
Tax Provision-3989000.00
Quarterly Earnings Growth Y O Y-0.968
Property Plant And Equipment Net149000.00
Retained Earnings-357803000.00
Cash And Short Term Investments362266000.00
Cash362266000.00
CodeATAI
Accounts Payable6004000.00
Net Debt-362266000.00
50 Day M A3.0897
Total Current Liabilities20935000.00
Currency CodeUSD
Non Current Assets Total39084000.00
Non Currrent Assets Other11176000.00
Please continue to Trending Equities. Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for ATAI Life Stock analysis

When running ATAI Life Sciences price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.97) 
Market Capitalization
585.5 M
Quarterly Revenue Growth YOY
(0.91) 
Return On Assets
(0.22) 
Return On Equity
(0.54) 
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI Life that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine ATAI Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.